PharmaEngine (4162.TWO) Stock Price

PharmaEngine Price

CLOSED
68.00TWD+3.60 (+5.44 %)
Market closed

Over the last 13 years PharmaEngine grew revenue by 17.2% annually, reaching 2.52 B TWD. Earnings per share have grown at 12.2% per year over the last 13 years. For PharmaEngine, the net margin of 69.4% is up versus 57.2% a few years ago. At today's price the dividend yield works out to roughly 2.21%. The payout ratio is around 12% of earnings. The consensus 12-month price target for PharmaEngine is 63.24 TWD, about 7.0% below where the stock trades today. Of 8 analysts, 0 rate the stock a buy — an overall Sell consensus. The stock trades about 28% above its 52-week low.

PharmaEngine stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of PharmaEngine over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how PharmaEngine stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing PharmaEngine's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

PharmaEngine Stock Price History
DatePharmaEngine Price
7/21/202668.00 TWD
7/20/202664.40 TWD
7/17/202663.70 TWD
7/16/202666.40 TWD
7/15/202667.40 TWD
7/14/202664.60 TWD
7/13/202665.80 TWD
7/10/202664.50 TWD
7/9/202664.50 TWD
7/8/202663.60 TWD
7/7/202663.80 TWD
7/6/202663.60 TWD
7/3/202663.70 TWD
7/2/202661.00 TWD
7/1/202662.70 TWD
6/30/202661.00 TWD
6/29/202659.60 TWD
6/26/202657.90 TWD
6/25/202659.00 TWD
6/24/202659.30 TWD
6/23/202657.60 TWD
6/22/202656.20 TWD
6/18/202657.30 TWD
6/17/202656.70 TWD
6/16/202656.50 TWD
6/15/202657.30 TWD
6/12/202657.60 TWD
6/11/202657.40 TWD
6/10/202657.20 TWD
6/9/202657.00 TWD
6/8/202656.50 TWD
6/5/202655.50 TWD
6/4/202655.70 TWD
6/3/202655.60 TWD
6/2/202654.90 TWD
6/1/202654.30 TWD
5/29/202653.60 TWD
5/28/202653.00 TWD
5/27/202654.10 TWD
5/26/202654.80 TWD
5/25/202656.00 TWD
5/22/202656.40 TWD
5/21/202657.10 TWD
5/20/202656.00 TWD
5/19/202655.20 TWD
5/18/202654.40 TWD
5/15/202655.00 TWD
5/14/202655.80 TWD
4/2/202659.00 TWD
4/1/202658.80 TWD
3/31/202657.50 TWD
3/30/202657.80 TWD
3/27/202658.50 TWD
3/26/202658.00 TWD
3/25/202658.00 TWD
3/24/202657.00 TWD
3/23/202656.90 TWD
3/20/202658.20 TWD
3/19/202656.70 TWD
3/18/202658.40 TWD
3/17/202658.40 TWD
3/16/202657.10 TWD
3/13/202657.20 TWD
3/12/202657.80 TWD
3/11/202659.50 TWD
3/10/202658.60 TWD
3/9/202657.60 TWD
3/6/202661.10 TWD
3/5/202661.90 TWD
3/4/202662.10 TWD
3/3/202662.80 TWD
3/2/202664.10 TWD
2/26/202665.00 TWD
2/25/202665.80 TWD
2/24/202666.20 TWD
2/23/202666.80 TWD
2/11/202664.60 TWD
2/10/202664.50 TWD
2/9/202663.60 TWD
2/6/202662.50 TWD
2/5/202664.50 TWD
2/4/202664.70 TWD
2/3/202664.50 TWD
2/2/202665.50 TWD
1/30/202666.50 TWD
1/29/202668.10 TWD
1/28/202668.20 TWD
1/27/202670.30 TWD
1/26/202669.90 TWD
1/23/202670.00 TWD
1/22/202669.00 TWD
1/21/202669.40 TWD
1/20/202670.20 TWD
1/19/202670.90 TWD
1/16/202671.10 TWD
1/15/202671.70 TWD
1/14/202670.50 TWD
1/13/202669.50 TWD
1/12/202670.70 TWD
1/9/202673.60 TWD
1/8/202673.10 TWD
1/7/202672.10 TWD
1/6/202670.90 TWD
1/5/202670.40 TWD
1/2/202671.90 TWD
12/31/202570.40 TWD
12/30/202570.10 TWD
12/29/202572.40 TWD
12/26/202571.60 TWD
12/24/202571.70 TWD
12/23/202572.20 TWD
12/22/202572.00 TWD
12/19/202573.00 TWD
12/18/202573.00 TWD
12/17/202572.20 TWD
12/16/202571.30 TWD
12/15/202571.00 TWD
12/12/202570.40 TWD
12/11/202572.30 TWD
12/10/202572.70 TWD
12/9/202573.80 TWD
12/8/202572.10 TWD
12/5/202572.60 TWD
12/4/202573.10 TWD
12/3/202572.50 TWD
12/2/202573.40 TWD
12/1/202571.70 TWD
11/28/202572.40 TWD
11/27/202572.70 TWD
11/26/202573.10 TWD
11/25/202572.80 TWD
11/24/202572.50 TWD
11/21/202569.70 TWD
11/20/202572.10 TWD
11/19/202570.50 TWD
11/18/202572.80 TWD
11/17/202571.10 TWD
11/14/202572.00 TWD
11/13/202572.00 TWD
11/12/202571.90 TWD
11/11/202568.50 TWD
11/10/202568.40 TWD
11/7/202568.00 TWD
11/6/202569.80 TWD
11/5/202571.40 TWD
11/4/202571.10 TWD
11/3/202570.50 TWD
10/31/202571.10 TWD
10/30/202566.90 TWD
10/29/202566.80 TWD
10/28/202568.00 TWD
10/27/202568.60 TWD
10/23/202567.80 TWD
10/22/202569.00 TWD
10/21/202568.60 TWD
10/20/202567.40 TWD
10/17/202567.40 TWD
10/16/202567.10 TWD
10/15/202567.40 TWD
10/14/202568.70 TWD
10/13/202569.30 TWD
10/9/202572.00 TWD
10/8/202570.40 TWD
10/7/202566.50 TWD
10/3/202566.90 TWD
10/2/202567.20 TWD
10/1/202567.70 TWD
9/30/202567.00 TWD
9/29/202566.20 TWD
9/26/202566.20 TWD
9/25/202567.40 TWD
9/24/202566.80 TWD
9/23/202565.90 TWD
9/22/202566.00 TWD
9/19/202565.80 TWD
9/18/202565.80 TWD
9/17/202564.40 TWD
9/16/202564.40 TWD
9/15/202564.40 TWD
9/12/202565.30 TWD
9/11/202564.90 TWD
9/10/202566.70 TWD
9/9/202567.30 TWD
9/8/202568.00 TWD
9/5/202567.80 TWD
9/4/202568.40 TWD
9/3/202568.20 TWD
9/2/202567.20 TWD
9/1/202565.90 TWD
8/29/202567.20 TWD
8/28/202568.00 TWD
8/27/202568.30 TWD
8/26/202567.50 TWD
8/25/202568.80 TWD
8/22/202567.30 TWD
8/21/202568.00 TWD
8/20/202565.20 TWD
8/19/202566.40 TWD
8/18/202566.70 TWD
8/15/202568.40 TWD
8/14/202570.10 TWD
8/13/202571.30 TWD
8/12/202578.00 TWD
8/11/202576.70 TWD
8/8/202577.90 TWD
8/7/202577.80 TWD
8/6/202579.20 TWD
8/5/202579.70 TWD
8/4/202576.40 TWD
8/1/202574.40 TWD
7/31/202574.10 TWD
7/30/202574.00 TWD
7/29/202576.10 TWD
7/28/202577.10 TWD
7/25/202577.80 TWD
7/24/202579.40 TWD
7/23/202578.00 TWD
Access this data via the Eulerpool API
Get Free API Key

PharmaEngine Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
314.04 M TWD
32.61 M TWD
42.55 M TWD
Jan 1, 2020
1.06 B TWD
809.71 M TWD
604.28 M TWD
Jan 1, 2021
654.84 M TWD
362.69 M TWD
426.03 M TWD
Jan 1, 2022
654.38 M TWD
282.74 M TWD
318.78 M TWD
Jan 1, 2023
767.67 M TWD
277.18 M TWD
274.65 M TWD
Jan 1, 2024
2.52 B TWD
2.05 B TWD
1.75 B TWD
Jan 1, 2025 (e)
898.16 M TWD
455.26 M TWD
382.63 M TWD
Jan 1, 2026 (e)
972.32 M TWD
518.09 M TWD
414.14 M TWD

PharmaEngine Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 22, 2026, 1:52 PM
 
REVENUEB TWD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB TWD
EBITB TWD
EBIT MARGIN%
NET INCOMEB TWD
NET INCOME GROWTH%
DIV.TWD
DIV. GROWTH%
SHARESM
201120122013201420152016201720182019202020212022202320242025e2026e
0.320.180.040.230.511.130.850.290.311.060.650.650.772.520.900.97
–-42.50-79.89516.22122.37123.67-24.78-65.657.17236.31-38.07–17.28228.94-64.418.24
97.1992.9345.9596.9398.6299.8299.6595.5689.8196.4094.3492.3593.6198.1098.1098.10
0.310.170.020.220.501.130.850.280.281.020.620.600.722.480.880.95
0.240.05-0.140.070.330.810.610.040.030.810.360.280.282.050.460.52
75.6326.63-375.6830.7064.5071.2571.7514.3310.1976.6155.3543.1236.1181.3750.6753.29
0.290.05-0.120.120.390.690.390.130.040.600.430.320.271.750.380.41
-693.75-83.16-343.75-205.13220.3374.87-43.83-66.67-67.441,338.10-29.47-25.35-13.84539.05-78.188.38
–––––––––––2.702.001.506.007.20
––––––––––––-25.93-25.00300.0020.00
105.25126.88135.17147.19147.99147.41147.76147.60145.73145.90144.74143.70143.74143.93143.93143.93
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales PharmaEngine generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue PharmaEngine retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare PharmaEngine's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares PharmaEngine has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against PharmaEngine's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

PharmaEngine stock margins

The PharmaEngine margin analysis displays the gross margin, EBIT margin, as well as the profit margin of PharmaEngine. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for PharmaEngine.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
89.87 %
10.38 %
13.55 %
Jan 1, 2020
96.47 %
76.68 %
57.22 %
Jan 1, 2021
94.34 %
55.39 %
65.06 %
Jan 1, 2022
92.41 %
43.21 %
48.72 %
Jan 1, 2023
93.66 %
36.11 %
35.78 %
Jan 1, 2024
98.11 %
81.37 %
69.39 %
Jan 1, 2025 (e)
98.11 %
50.69 %
42.60 %
Jan 1, 2026 (e)
98.11 %
53.28 %
42.59 %

PharmaEngine Stock Revenue, EBIT, Earnings per Share

The PharmaEngine earnings per share therefore indicates how much revenue PharmaEngine has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2019
2.15 TWD
0.22 TWD
0.29 TWD
Jan 1, 2020
7.24 TWD
5.55 TWD
4.14 TWD
Jan 1, 2021
4.52 TWD
2.51 TWD
2.94 TWD
Jan 1, 2022
4.55 TWD
1.97 TWD
2.22 TWD
Jan 1, 2023
5.34 TWD
1.93 TWD
1.91 TWD
Jan 1, 2024
17.53 TWD
14.27 TWD
12.17 TWD
Jan 1, 2025 (e)
6.17 TWD
3.16 TWD
2.63 TWD
Jan 1, 2026 (e)
6.67 TWD
3.60 TWD
2.84 TWD

PharmaEngine business model & stock analysis

PharmaEngine Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

PharmaEngine historical P/E ratio, EBIT multiple, and P/S ratio

PharmaEngine annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

PharmaEngine shares outstanding

The number of shares of PharmaEngine was 143.93 M in 2025. This indicates how many shares PharmaEngine is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2019
145.73 M Stocks
Jan 1, 2020
145.90 M Stocks
Jan 1, 2021
144.74 M Stocks
Jan 1, 2022
143.70 M Stocks
Jan 1, 2023
143.74 M Stocks
Jan 1, 2024
143.93 M Stocks
Jan 1, 2025 (e)
143.93 M Stocks
Jan 1, 2026 (e)
143.93 M Stocks

PharmaEngine stock splits

In PharmaEngine's history, there have been no stock splits.

PharmaEngine Dividend History

4 years of dividend payments

YearAnnual DividendYoY ChangePayments
20256.00TWD↑ 300.0%1×
Aug 13, 20256.00TWD↑ 300.0%1/1
20241.50TWD↓ 25.0%1×
20232.00TWD↓ 25.9%1×
20222.70TWD—1×

PharmaEngine dividend history and estimates

In 2025, PharmaEngine paid a dividend amounting to 6.00 TWD. Dividend means that PharmaEngine distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2022
2.70 TWD
0.00 TWD
Jan 1, 2023
2.00 TWD
0.00 TWD
Jan 1, 2024
1.50 TWD
0.00 TWD
Jan 1, 2025
6.00 TWD
0.00 TWD
Jan 1, 2026 (e)
0.00 TWD
7.20 TWD

PharmaEngine dividend payout ratio

In 2025, PharmaEngine had a payout ratio of 228.44%. The payout ratio indicates the percentage of the company's profits that PharmaEngine distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2019
79.54 %
Jan 1, 2020
79.54 %
Jan 1, 2021
79.54 %
Jan 1, 2022
121.62 %
Jan 1, 2023
104.67 %
Jan 1, 2024
12.33 %
Jan 1, 2025 (e)
228.44 %
Jan 1, 2026 (e)
253.27 %

Current PharmaEngine forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy0.00 % (0)
Hold50.00 % (4)
Sell50.00 % (4)
12M Price Target
63.24
Last Price
68.00
Currency
TWD
12M Return Potential
-7.00 %
LTM Return
0 %

PharmaEngine Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
4/25/20240.57TWD185.40 MTWD2024 Q1
2/29/20240.47TWD191.58 MTWD2023 Q4

PharmaEngine shareholder structure

% Name
17.75604%
TTY Biopharm Company Limited
TTY Biopharm Company Limited
15.50384%
National Development Fund, Executive Yuan
National Development Fund, Executive Yuan
2.21650%
Zeng (Bao Qing)
Zeng (Bao Qing)
1.91589%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
0.99327%
Yeh (Chang Ching)
Yeh (Chang Ching)
0.88550%
TransGlobe Life Insurance Inc.
TransGlobe Life Insurance Inc.

PharmaEngine Executives and Management Board

JH

Mr. Jan-Yau Hsu

Chairman of the Board · since 2022

Compensation4.52 M TWD
CL

Mr. Chien-Huang Lin

Independent Director

Compensation1.68 M TWD
MH

Mr. Ming-Feng Hou

Director

Compensation1.26 M TWD
WH

Ms. Wen-Hung Hsu

Director

Compensation84,000.00 TWD
MW

Mr. Ming-Shiang Wu

Director

Compensation84,000.00 TWD

Frequently asked questions about PharmaEngine

Analysts currently set an average price target of 63.24 TWD for the PharmaEngine stock (median: 63.24 TWD), implying -7.0 % versus the latest price. The consensus is based on 8 analyst ratings.

PharmaEngine Analyst Price Targets 2026

All fundamentals and in-depth analysis of PharmaEngine

Our stock analysis for PharmaEngine stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PharmaEngine. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

PharmaEngine Stock
PharmaEngine Revenue→
PharmaEngine Stock
PharmaEngine Net Income→
PharmaEngine Stock
PharmaEngine P/E→
PharmaEngine Stock
PharmaEngine P/S→
PharmaEngine Stock
PharmaEngine EBIT→
PharmaEngine Stock
PharmaEngine Dividend→
PharmaEngine Stock
PharmaEngine Directors Dealings→
PharmaEngine Stock
PharmaEngine Stocks→
PharmaEngine Stock
PharmaEngine Market capitalization→
PharmaEngine Stock
PharmaEngine Debt→
PharmaEngine Stock
PharmaEngine Liabilities→
PharmaEngine Stock
PharmaEngine Equity→
PharmaEngine Stock
PharmaEngine AAQS→
PharmaEngine Stock
PharmaEngine Employees→
PharmaEngine Stock
PharmaEngine ROE→
PharmaEngine Stock
PharmaEngine ROA→
PharmaEngine Stock
PharmaEngine ROCE→
PharmaEngine Stock
PharmaEngine News→
PharmaEngine Stock
PharmaEngine Analyst Price Targets→

Health Stocks

Pharmagreen BiotechPharmaCyte BiotechPharmaids PharmaceuticalsPharmacom BiovetPharmaResearch CoPharmacieloPharmaResources (Shanghai) CoPharmaBlock Sciences NanjingPharmaron Beijing CoPharma-Bio ServPharmesis InternationalPharma MarAll Stocks A–Z →